Molecular weight (DA)
105kD
Immunogen
Synthesized peptide derived from human SYAC AA range: 504-554
Specificity
This antibody detects endogenous levels of SYAC at Human/Mouse/Rat
Source
Polyclonal, Rabbit,IgG
Formulation
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.278% sodium azide.
Dilution rate
WB 1:500-2000
Purification process (Immunogen)
The antibody was affinity-purified from rabbit serum by affinity-chromatography using specific immunogen.
Background
The human alanyl-tRNA synthetase (AARS) belongs to a family of tRNA synthases, of the class II enzymes. Class II tRNA synthases evolved early in evolution and are highly conserved. This is reflected by the fact that 498 of the 968-residue polypeptide human AARS shares 41% identity witht the E.coli protein. tRNA synthases are the enzymes that interpret the RNA code and attach specific aminoacids to the tRNAs that contain the cognate trinucleotide anticodons. They consist of a catalytic domain which interacts with the amino acid acceptor-T psi C helix of the tRNA, and a second domain which interacts with the rest of the tRNA structure. [provided by RefSeq, Jul 2008],
Function
catalytic activity:ATP + L-alanine + tRNA(Ala) = AMP + diphosphate + L-alanyl-tRNA(Ala).,similarity:Belongs to the class-II aminoacyl-tRNA synthetase family.,subunit:Monomer.,
Other name
Alanine--tRNA ligase, cytoplasmic (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS) (Renal carcinoma antigen NY-REN-42)
Fields
>>Aminoacyl-tRNA biosynthesis
Human protein sequence Database
P49588
Mouse protein sequence database
Q8BGQ7
Rat protein sequence database
P50475
Cellular localization
Cytoplasm .
Tissue expression
Epithelium,Liver,Osteosarcoma,Placenta,Renal cell carcinoma,